STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation

Cancer Cell

Volumn 22, Issue 4, 2012, Pages 466-478

  Tye, Hazel ^a   Kennedy, Catherine L ^a   Najdovska, Meri ^a   McLeod, Louise ^a   McCormack, William ^b   Hughes, Norman ^c   Dev, Anouk ^a   Sievert, William ^a   Ooi, Chia Huey ^d   Ishikawa, Tomo O ^e   Oshima, Hiroko ^e   Bhathal, Prithi S ^c   Parker, Andrew E ^b   Oshima, Masanobu ^e   Tan, Patrick ^d,f,g   Jenkins, Brendan J ^a  

^a MONASH UNIVERSITY   (Australia)

^b ST JAMES S HOSPITAL   (Ireland)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e KANAZAWA UNIVERSITY   (Japan)

^f GENOME INSTITUTE OF SINGAPORE   (Singapore)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; OPN 301; STAT3 PROTEIN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; DISEASE ASSOCIATION; GENE ACTIVATION; GENE FUNCTION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; UPREGULATION;

EID: 84867605321     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2012.08.010     Document Type: Article

References (61)

1. Arslan F., Smeets M.B., O'Neill L.A., Keogh B., McGuirk P., Timmers L., Tersteeg C., Hoefer I.E., Doevendans P.A., Pasterkamp G., de Kleijn D.P. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 2010, 121:80-90.
2. Asciutti S., Akiri G., Grumolato L., Vijayakumar S., Aaronson S.A. Diverse mechanisms of Wnt activation and effects of pathway inhibition on proliferation of human gastric carcinoma cells. Oncogene 2011, 30:956-966.
3. Beier F., Lee R.J., Taylor A.C., Pestell R.G., LuValle P. Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes. Proc. Natl. Acad. Sci. USA 1999, 96:1433-1438.
4. Bollrath J., Greten F.R. IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep. 2009, 10:1314-1319.
5. Bollrath J., Phesse T.J., von Burstin V.A., Putoczki T., Bennecke M., Bateman T., Nebelsiek T., Lundgren-May T., Canli O., Schwitalla S., et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 2009, 15:91-102.
6. Boulon S., Dantonel J.C., Binet V., Vié A., Blanchard J.M., Hipskind R.A., Philips A. Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB- and CREB binding protein-independent mechanism. Mol. Cell. Biol. 2002, 22:7769-7779.
7. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Stat3 as an oncogene. Cell 1999, 98:295-303.
8. Cario E., Gerken G., Podolsky D.K. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007, 132:1359-1374.
9. Cinti C., Vindigni C., Zamparelli A., La Sala D., Epistolato M.C., Marrelli D., Cevenini G., Tosi P. Activated Akt as an indicator of prognosis in gastric cancer. Virchows Arch. 2008, 453:449-455.
10. Dixon M.F., Genta R.M., Yardley J.H., Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 1996, 20:1161-1181.
11. El-Omar E.M., Rabkin C.S., Gammon M.D., Vaughan T.L., Risch H.A., Schoenberg J.B., Stanford J.L., Mayne S.T., Goedert J., Blot W.J., et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003, 124:1193-1201.
12. Ellmark P., Ingvarsson J., Carlsson A., Lundin B.S., Wingren C., Borrebaeck C.A. Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol. Cell. Proteomics 2006, 5:1638-1646.
13. Ernst M., Najdovska M., Grail D., Lundgren-May T., Buchert M., Tye H., Matthews V.B., Armes J., Bhathal P.S., Hughes N.R., et al. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J. Clin. Invest. 2008, 118:1727-1738.
14. Gao L., Zhang L., Hu J., Li F., Shao Y., Zhao D., Kalvakolanu D.V., Kopecko D.J., Zhao X., Xu D.Q. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo. Clin. Cancer Res. 2005, 11:6333-6341.
15. Gong W., Wang L., Yao J.C., Ajani J.A., Wei D., Aldape K.D., Xie K., Sawaya R., Huang S. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Clin. Cancer Res. 2005, 11:1386-1393.
16. Hold G.L., Rabkin C.S., Chow W.H., Smith M.G., Gammon M.D., Risch H.A., Vaughan T.L., McColl K.E., Lissowska J., Zatonski W., et al. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007, 132:905-912.
17. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 1999, 162:3749-3752.
18. Huang B., Zhao J., Shen S., Li H., He K.L., Shen G.X., Mayer L., Unkeless J., Li D., Yuan Y., et al. Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. Cancer Res. 2007, 67:4346-4352.
19. Itadani H., Oshima H., Oshima M., Kotani H. Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer. BMC Genomics 2009, 10:615-622.
20. Jenkins B.J., Grail D., Nheu T., Najdovska M., Wang B., Waring P., Inglese M., McLoughlin R.M., Jones S.A., Topley N., et al. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat. Med. 2005, 11:845-852.
21. Joyce D., Bouzahzah B., Fu M., Albanese C., D'Amico M., Steer J., Klein J.U., Lee R.J., Segall J.E., Westwick J.K., et al. Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J. Biol. Chem. 1999, 274:25245-25249.
22. Kawada M., Seno H., Uenoyama Y., Sawabu T., Kanda N., Fukui H., Shimahara Y., Chiba T. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer. Cancer Res. 2006, 66:2913-2917.
23. Kawai T., Akira S. TLR signaling. Cell Death Differ. 2006, 13:816-825.
24. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
25. Kim D.W., Gazourian L., Quadri S.A., Romieu-Mourez R., Sherr D.H., Sonenshein G.E. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene 2000, 19:5498-5506.
26. Kortylewski M., Kujawski M., Wang T., Wei S., Zhang S., Pilon-Thomas S., Niu G., Kay H., Mulé J., Kerr W.G., et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat. Med. 2005, 11:1314-1321.
27. Li Z., Chen J., Chan K.W., Qiao L., Wong B.C.Y. A possible role of cIAP2 in Helicobacter pylori-associated gastric cancer. Cancer Lett. 2011, 313:192-200.
28. Liang B., Wang S., Zhu X.G., Yu Y.X., Cui Z.R., Yu Y.Z. Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer. World J. Gastroenterol. 2005, 11:623-628.
29. Lim J.W., Kim H., Kim K.H. Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells. Lab. Invest. 2001, 81:349-360.
30. Lowe E.L., Crother T.R., Rabizadeh S., Hu B., Wang H., Chen S., Shimada K., Wong M.H., Michelsen K.S., Arditi M. Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer. PLoS ONE 2010, 5:e13027.
31. Mellett M., Atzei P., Jackson R., O'Neill L.A., Moynagh P.N. Mal mediates TLR-induced activation of CREB and expression of IL-10. J. Immunol. 2011, 186:4925-4935.
32. Meng G., Rutz M., Schiemann M., Metzger J., Grabiec A., Schwandner R., Luppa P.B., Ebel F., Busch D.H., Bauer S., et al. Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J. Clin. Invest. 2004, 113:1473-1481.
33. Ogata H., Kobayashi T., Chinen T., Takaki H., Sanada T., Minoda Y., Koga K., Takaesu G., Maehara Y., Iida M., Yoshimura A. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology 2006, 131:179-193.
34. Ooi C.H., Ivanova T., Wu J., Lee M., Tan I.B., Tao J., Ward L., Koo J.H., Gopalakrishnan V., Zhu Y., et al. Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet. 2009, 5:e1000676.
35. Oshima H., Matsunaga A., Fujimura T., Tsukamoto T., Taketo M.M., Oshima M. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology 2006, 131:1086-1095.
36. Park I.C., Lee S.H., Whang D.Y., Hong W.S., Choi S.S., Shin H.S., Choe T.B., Hong S.I. Expression of a novel Bcl-2 related gene, Bfl-1, in various human cancers and cancer cell lines. Anticancer Res. 1997, 17(6D):4619-4622.
37. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108.
38. Rakoff-Nahoum S., Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 2007, 317:124-127.
39. Rebouissou S., Amessou M., Couchy G., Poussin K., Imbeaud S., Pilati C., Izard T., Balabaud C., Bioulac-Sage P., Zucman-Rossi J. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009, 457:200-204.
40. Rosenstiel P., Hellmig S., Hampe J., Ott S., Till A., Fischbach W., Sahly H., Lucius R., Fölsch U.R., Philpott D., Schreiber S. Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell. Microbiol. 2006, 8:1188-1198.
41. Salcedo R., Worschech A., Cardone M., Jones Y., Gyulai Z., Dai R.M., Wang E., Ma W., Haines D., O'hUigin C., et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J. Exp. Med. 2010, 207:1625-1636.
42. Sasada T., Takedatsu H., Azuma K., Koga M., Maeda Y., Shichijo S., Shoumura H., Hirai T., Takabayashi A., Itoh K. Immediate early response gene X-1, a stress-inducible antiapoptotic gene, encodes cytotoxic T-lymphocyte (CTL) epitopes capable of inducing human leukocyte antigen-A33-restricted and tumor-reactive CTLs in gastric cancer patients. Cancer Res. 2004, 64:2882-2888.
43. Sasaki N., Morisaki T., Hashizume K., Yao T., Tsuneyoshi M., Noshiro H., Nakamura K., Yamanaka T., Uchiyama A., Tanaka M., Katano M. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin. Cancer Res. 2001, 7:4136-4142.
44. Schiechl G., Bauer B., Fuss I., Lang S.A., Moser C., Ruemmele P., Rose-John S., Neurath M.F., Geissler E.K., Schlitt H.J., et al. Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages. J. Clin. Invest. 2011, 121:1692-1708.
45. Shaykhiev R., Behr J., Bals R. Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival. PLoS ONE 2008, 3:e1393.
46. Shcheblyakov D.V., Logunov D.Y., Rakovskaya I.V., Shmarov M.M., Naroditsky B.S., Ginzburg A.L. Triggering of toll-like receptor-2 in mouse myelomonocytic leukaemia cells WEHI-3B leads to the suppression of apoptosis and promotes tumor progression in vivo. Acta Naturae 2011, 3:83-93.
47. Tahara T., Arisawa T., Wang F., Shibata T., Nakamura M., Sakata M., Hirata I., Nakano H. Toll-like receptor 2-196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer. Cancer Sci. 2007, 98:1790-1794.
48. Takano Y., Kato Y., van Diest P.J., Masuda M., Mitomi H., Okayasu I. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am. J. Pathol. 2000, 156:585-594.
49. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999, 11:443-451.
50. Tebbutt N.C., Giraud A.S., Inglese M., Jenkins B.J., Waring P., Clay F.J., Malki S., Alderman B.M., Grail D., Hollande F., et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 2002, 8:1089-1097.
51. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N., Schlemper R.J. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001, 345:784-789.
52. Uno K., Kato K., Atsumi T., Suzuki T., Yoshitake J., Morita H., Ohara S., Kotake Y., Shimosegawa T., Yoshimura T. Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293:G1004-G1012.
53. Vartanian R., Masri J., Martin J., Cloninger C., Holmes B., Artinian N., Funk A., Ruegg T., Gera J. AP-1 regulates cyclin D1 and c-MYC transcription in an AKT-dependent manner in response to mTOR inhibition: role of AIP4/Itch-mediated JUNB degradation. Mol. Cancer Res. 2011, 9:115-130.
54. Viala J., Chaput C., Boneca I.G., Cardona A., Girardin S.E., Moran A.P., Athman R., Mémet S., Huerre M.R., Coyle A.J., et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 2004, 5:1166-1174.
55. Walser T., Cui X., Yanagawa J., Lee J.M., Heinrich E., Lee G., Sharma S., Dubinett S.M. Smoking and lung cancer: the role of inflammation. Proc. Am. Thorac. Soc. 2008, 5:811-815.
56. Wang J., Ma J., Charboneau R., Barke R., Roy S. Morphine inhibits murine dendritic cell IL-23 production by modulating Toll-like receptor 2 and Nod2 signaling. J. Biol. Chem. 2011, 286:10225-10232.
57. West X.Z., Malinin N.L., Merkulova A.A., Tischenko M., Kerr B.A., Borden E.C., Podrez E.A., Salomon R.G., Byzova T.V. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 2010, 467:972-976.
58. Yakata Y., Nakayama T., Yoshizaki A., Kusaba T., Inoue K., Sekine I. Expression of p-STAT3 in human gastric carcinoma: significant correlation in tumour invasion and prognosis. Int. J. Oncol. 2007, 30:437-442.
59. Yang H.Z., Cui B., Liu H.Z., Mi S., Yan J., Yan H.M., Hua F., Lin H., Cai W.F., Xie W.J., et al. Blocking TLR2 activity attenuates pulmonary metastases of tumor. PLoS ONE 2009, 4:e6520.
60. Yang J., Liao X., Agarwal M.K., Barnes L., Auron P.E., Stark G.R. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev. 2007, 21:1396-1408.
61. Yokota S., Okabayashi T., Rehli M., Fujii N., Amano K. Helicobacter pylori lipopolysaccharides upregulate toll-like receptor 4 expression and proliferation of gastric epithelial cells via the MEK1/2-ERK1/2 mitogen-activated protein kinase pathway. Infect. Immun. 2010, 78:468-476.